Lonza's SSP for Early Phase Delivery
Lonza, the leading custom manufacturer of chemical intermediates and active ingredients as well as biopharmaceuticals for the pharmaceutical and agrochemical industries, has recently expanded into a new state-ofthe-art seven-storey small-scale plant (SSP) whose task is to satisfy both clin...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | deu |
| Published: |
Swiss Chemical Society
2005-01-01
|
| Series: | CHIMIA |
| Subjects: | |
| Online Access: | https://chimia.ch/chimia/article/view/3935 |
| _version_ | 1811214010578632704 |
|---|---|
| author | Beat Schmidt |
| author_facet | Beat Schmidt |
| author_sort | Beat Schmidt |
| collection | DOAJ |
| description |
Lonza, the leading custom manufacturer of chemical intermediates and active ingredients as well as biopharmaceuticals for the pharmaceutical and agrochemical industries, has recently expanded into a new state-ofthe-art seven-storey small-scale plant (SSP) whose task is to satisfy both
clinical supply and process development with sophisticated and lean cGMP-compliant equipment. With this investment, Lonza has now closed the gap between kilo lab and launch plant in order to provide one-stop shopping for API and drug product developmentthrough-approval.
|
| first_indexed | 2024-04-12T05:57:24Z |
| format | Article |
| id | doaj.art-7d28eaee883c40bcbe297623e7811caa |
| institution | Directory Open Access Journal |
| issn | 0009-4293 2673-2424 |
| language | deu |
| last_indexed | 2024-04-12T05:57:24Z |
| publishDate | 2005-01-01 |
| publisher | Swiss Chemical Society |
| record_format | Article |
| series | CHIMIA |
| spelling | doaj.art-7d28eaee883c40bcbe297623e7811caa2022-12-22T03:45:08ZdeuSwiss Chemical SocietyCHIMIA0009-42932673-24242005-01-01591-210.2533/000942905777676885Lonza's SSP for Early Phase DeliveryBeat Schmidt Lonza, the leading custom manufacturer of chemical intermediates and active ingredients as well as biopharmaceuticals for the pharmaceutical and agrochemical industries, has recently expanded into a new state-ofthe-art seven-storey small-scale plant (SSP) whose task is to satisfy both clinical supply and process development with sophisticated and lean cGMP-compliant equipment. With this investment, Lonza has now closed the gap between kilo lab and launch plant in order to provide one-stop shopping for API and drug product developmentthrough-approval. https://chimia.ch/chimia/article/view/3935CgmpCmoInvestmentLonzaSmall-scale plant |
| spellingShingle | Beat Schmidt Lonza's SSP for Early Phase Delivery CHIMIA Cgmp Cmo Investment Lonza Small-scale plant |
| title | Lonza's SSP for Early Phase Delivery |
| title_full | Lonza's SSP for Early Phase Delivery |
| title_fullStr | Lonza's SSP for Early Phase Delivery |
| title_full_unstemmed | Lonza's SSP for Early Phase Delivery |
| title_short | Lonza's SSP for Early Phase Delivery |
| title_sort | lonza s ssp for early phase delivery |
| topic | Cgmp Cmo Investment Lonza Small-scale plant |
| url | https://chimia.ch/chimia/article/view/3935 |
| work_keys_str_mv | AT beatschmidt lonzassspforearlyphasedelivery |